Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases (original) (raw)
References
Singer, C., Kaplan, M. H., Armstrong, D. Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am. J. Med. 62 (1977) 731–742. Google Scholar
Bodey, G. P., Rodriguez, V., Chang, H. Y., Narboni, G. Fever and infection in leukemic patients. A study of 494 consecutive patients. Cancer 41 (1978) 1610–1622. Google Scholar
Wade, J. C., Schimpff, S. C., Newman, K. A., Wiernik, P. H.Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann. Intern. Med. 97 (1982) 503–508. Google Scholar
Winston, D. J., Dudnick, D. V., Chapin, M., Ho, W. G., Gale, R. P., Martin, W. J. Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch. Intern. Med. 143 (1983) 32–36. Google Scholar
Cohen, J., Donnelly, J. P., Worsley, A. M., Catovsky, D., Goldman, J. M., Galton, D. A. G. Septicemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet ii (1983) 1452–1454. Google Scholar
Brown, A. E. Neutropenia, fever, and infection. Am. J. Med. 76 (1984) 421–428. Google Scholar
Henslee, J., Bostrom, B., Weisdorf, D., Ramsay, N., McGlave, P., Kersey, J. Streptococcal sepsis in bone marrow transplant patients. Lancet i (1984) 393. Google Scholar
Venditti, M., Baiocchi, P., Santini, C., Brandimarte, C., Serra, P., Gentile, G., Girmenia, C., Martino, P. Antimicrobial susceptibility of_Streptococcus_ species that cause septicemia in neutropenic patients. Antimicrob. Agents Chemother. 33 (1989) 580–582. Google Scholar
Kern, W., Kurrle, E., Vanek, E. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. Klin. Wochenschr. 65 (1987) 773–780. Google Scholar
Langley, J., Gold, R. Sepsis in febrile neutropenic patients with cancer. Pediatr. Infect. Dis. J. 7 (1988) 34–37. Google Scholar
Menichetti, F., Del Favero, A., Guerciolini, R., Tonato, M., Frongillo, R. F., Roila, F., Pauluzzi, S. Viridans streptococci septicemia in cancer patients: a clinical study. Eur. J. Epidemiol. 3 (1987) 316–318. Google Scholar
Santini, C. Emergence of penicillin-resistant viridans streptococci causing septicemia in granulocytopenic patients. Eur. J. Epidemiol. 4 (1988) 391–392. Google Scholar
Peters, W. G., Willemze, R., Colly, L. P., Guiot, H. F. L. Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma. Netherl. J. Med. 30 (1987) 64–74. Google Scholar
Guiot, H. F. L., van den Broek, P. J., van der Meer, J. W. M., Peters, W. G., Willemze, R., van Furth, R. The association between streptococcal infection and interstitial pneumonia in chemotherapy and BMT. Bone Marr. Transpl. 3 (Suppl. 1) (1988) 274. Google Scholar
Schmeiser, T., Kurrle, E., Arnold, R., Wiesneth, M., Bunjes, D., Hertenstein, B., Kern, W., Heit, W., Heimpel, H. Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation. Scand. J. Infect. Dis. 20 (1988) 625–631. Google Scholar
Kern, W., Kurrle, E., Vanek, E. Ofloxacin for prevention of bacterial infections in granulocytopenic patients. Infection 15 (1987) 427–432. Google Scholar
Kurrle, E., Dekker, A. W., Gaus, W., Haralambie, E., Krieger, D., Rozenberg-Arska, M., De Vries-Hospers, H. G., Van der Waaij, D., Wendt, F. Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis. Infection 14 (1986) 226–232. Google Scholar
Facklam, R. R., Carey, R. B. Streptococci and aerococci. In:Lennette, E. H., Balows, A., Hausler, W. J. Jr., Shadomy, H. J. (eds.): Manual of clinical microbiology, 4th edition, American Society for Microbiology, Washington, D. C. 1985, pp. 154–175. Google Scholar
Duma, R. J., Weinberg, A. N., Medrek, T. F., Kunz, L. J. Streptococcal infections. A bacteriologic and clinical study of streptococcal bacteremia. Medicine 48 (1969) 87–127. Google Scholar
Parker, M. T., Ball, L. C. Streptococci and aerococci associated with systemic infection in man. J. Med. Microbiol. 9 (1976) 275–302. Google Scholar
Hoecker, J. L., Pickering, L. K., Gröschel, D., Kohl, S.Streptococcus salivarius sepsis in children with malignancies. J. Pediatr. 92 (1978) 337–338. Google Scholar
Boggs, D. R., Frei, E. III Clinical studies of fever and infections in cancer. Cancer 13 (1960) 1240–1253. Google Scholar
Hersh, E. M., Bodey, G. P., Nies, B. A., Freireich, E. J. Causes of death in acute leukemia. A ten year study of 414 patients from 1954–1963. J. Am. Med. Assoc. 193 (1965) 105–109. Google Scholar
Schimpff, S. C., Young, V. M., Greene, W. H., Vermeulen, G. D., Moody, M. R., Wiernik, P. H. Origin of infection in acute nonlymphocytic leukemia: significance of hospital acquisition of potential pathogens. Ann. Intern. Med. 77 (1972) 707–714. Google Scholar
Chang, H. Y., Rodriguez, V., Narboni, G., Bodey, G. P., Luna, M. A., Freireich, E. J. Causes of death in adults with acute leukemia. Medicine 55 (1976) 259–268. Google Scholar
Gurwith, M. J., Brunton, J. L., Lank, B. A., Ronald, A. R., Harding, G. K. M. Granulocytpenia in hospitalized patients. I. Prognostic factors and etiology of fever. Am. J. Med. 64 (1978) 121–126. Google Scholar
Bishop, J. F., Schimpff, S. C., Diggs, C. H., Wiernik, P. H. Infection during intense chemotherapy for non-Hodgkin's lymphoma. Ann. Intern. Med. 95 (1981) 549–555. Google Scholar
Brunn, B., Bangsborg, J., Hovgaard, D., Skinhj, P. Bacteremia and candidemia in hematological malignancies: microbiological findings and antibiotic susceptibilities. Scand. J. Infect. Dis. 20 (1988) 503–509. Google Scholar
Kilton, L. J., Fossieck, B. E., Cohen, M. H., Parker, R. H. Bacteremia due to gram-positive cocci in patients with neoplastic disease. Am. J. Med. 66 (1979) 596–602. Google Scholar
Bodey, G. P. Infection in cancer patients. A continuing association. Am. J. Med. 81 (Suppl. 1A) (1986) 11–26. Google Scholar
Duffy, T. P. How much is too much high-dose cytosine arabinoside? J. Clin. Oncol. 3 (1985) 601–603. Google Scholar
Wolff, S. N., Marion, J., Stein, R. S., Flexner, J. M., Lazarus, H. M., Spitzer, T. R., Phillips, G. L., Herzig, R. H., Herzig, G. P. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study. Blood 65 (1985) 1407–1411. Google Scholar
Maschmeyer, G., Rosenthal, E., Wendt, F. Bacteriologic surveillance during long-term administration of 4-quinolones. Rev. Infect. Dis. 11 (Suppl. 5) (1989) S1238-S1239. Google Scholar
Winston, D. J., Ho, W. G., Gale, R. P., Champlin, R. E. Prophylaxis of infection in bone marrow transplants. Eur. J. Cancer Clin. Oncol. 24 (Suppl. 1) (1988) 15–23. Google Scholar
Winston, D. J., Ho, W. G., Nakao, S. L., Gale, R. P., Champlin, R. E. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am. J. Med. 80 (1986) 884–890. Google Scholar
Karp, J. E., Merz, W. G., Hendricksen, C., Laughon, B., Redden, T., Bamberger, B. J., Bartlett, J. G., Saral, R., Burke, P. J. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. Ann. Intern. Med. 106 (1987) 1–7. Google Scholar
Rozenberg-Arska, M., Dekker, A., Verdonck, L., Verhoef, J. Prevention of bacteremia caused by α-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin. Infection 17 (1989) 240–244. Google Scholar
Winston, D. J., Ho, W. G., Champlin, R. E., Karp, J., Bartlett, J., Finley, R. S., Joshi, J. H., Talbot, G., Levitt, L., Deresenski, S., Carrado, M. Norfloxacin for prevention of bacterial infections in granulocytopenic patients. Am. J. Med. 82 (Suppl. 6B) (1986) 40–46. Google Scholar
Cruciani, M., Concia, E., Navarra, A., Perversi, L., Bonetti, F., Arico, M., Nespoli, L. Prophylactic co-trimoxazole versus norfloxacin in neutropenic patients — prospective randomized study. Infection 17 (1989) 65–69. Google Scholar
Rozenberg-Arska, M., Dekker, A. W., Verhoef, J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J. Infect. Dis. 152 (1985) 104–107. Google Scholar
Dekker, A. W., Rozenberg-Arska, M., Verhoef, J. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole. Ann. Intern. Med. 106 (1987) 7–12. Google Scholar
Maschmeyer, G., Haralambie, E., Gaus, W., Kern, W., Dekker, A. W., De Vries-Hospers, H. G., Sizoo, W., König, W., Gutzler, F., Daenen, S. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Infection 16 (1988) 334–339. Google Scholar
Bow, E. J., Rayner, E., Louie, T. J. Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. Am. J. Med. 84 (1988) 847–854. Google Scholar
Enno, A., Catovsky, D., Darrell, J., Goldman, J. M., Hows, J., Galton, D. A. G. Cotrimoxazole for prevention of infection in acute leukemia. Lancet ii (1978) 395–397. Google Scholar
Gurwith, M. J., Brunton, J. L., Lank, B. A., Harding, G. K. M., Ronald, A. R. A prospective controlled investigation of prophylactic trimethoprim-sulfamethoxazole in hospitalized granulocytopenic patients. Am. J. Med. 66 8 (1979) 248–256. Google Scholar
Dekker, A. W., Rozenberg-Arska, M., Sixma, J. J., Verhoef, J. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia. Ann. Intern. Med. 95 (1981) 555–559. Google Scholar
Guiot, H. F. L., van der Meer, J. W., van Furth, R. Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J. Infect. Dis. 143 (1981) 644–654. Google Scholar
Wade, J. C., Schimpff, S. C., Hargadon, M. T., Fortner, C. L., Young, V. M., Wiernik, P. H. A comparison of trimethoprim/sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infection in acute leukemia. N. Engl. J. Med. 304 (1981) 1057–1062. Google Scholar
Weiser, B., Lange, M., Fialk, M. A., Singer, C., Szatrowski, T. H., Armstrong, D. Prophylactic trimethoprim/sulfamethoxazole during consolidation chemotherapy for acute leukemia. A controlled trial. Ann. Intern. Med. 95 (1981) 436–438. Google Scholar
Starke, I. D., Donelly, J. P., Catovsky, D., Darrrell, J., Johnson, S. A., Goldman, J. M., Galton, D. A. G. Cotrimoxazole alone for prevention of bacterial infection in patients with acute leukemia. Lancet i (1982) 5–6. Google Scholar
Watson, J. G., Jameson, B., Powles, R. L., McElwain, T. J., Lawson, D. N., Judson, I., Morgenstern, G. R., Lumley, H., Kay, H. E. M. Cotrimoxazole vs. nonabsorbable antibiotics in acute leukemia. Lancet i (1982) 6–9. Google Scholar
Gualtieri, R. J., Donowitz, G. R., Kaiser, D. L., Hess, C. E., Sande, M. A. Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies. Am. J. Med. 74 (1983) 934–940. Google Scholar
Guiot, H. F. L., van den Broek, P. J., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study. J. Infect. Dis. 147 (1983) 615–623. Google Scholar
Kauffman, C. A., Liepman, M. K., Bergman, A. G., Midduszewski, J. Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients: reduction of infections and effect on bacterial and fungal flora. Am. J. Med. 74 (1983) 599–607. Google Scholar
Wade, J., DeJongh, C., Newman, K., Wiernik, P., Schimpff, S. C. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. J. Infect. Dis. 147 (1983) 624–634. Google Scholar
Henry, S. A., Armstrong, D., Kempin, S., Gee, T., Arlin, Z., Clarkson, B. Oral trimethoprim-sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia. Am. J. Med. 77 (1984) 663–666. Google Scholar
Van Furth, R., Guiot, H. F. L. Modulation of the host flora. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 1–7. Google Scholar
Rozenberg-Arska, M., Dekker, A. W., Verhoef, J. Prevention of infections in granulocytopenic patients by fluorinated quinolones. Rev. Infect. Dis. 11 (Suppl. 5) (1989) S1231-S1236. Google Scholar
Swenson, F. J., Rubin, S. J. Clinical significance of viridans group streptococci isolated from blood cultures. J. Clin. Microbiol. 15 (1982) 725–727. Google Scholar
Broome, C. V., Moellering, R. C. Jr., Watson, B. K. Clinical significance of Lancefield groups L-T streptococci isolated from blood and cerebrospinal fluid. J. Infect. Dis. 133 (1976) 382–392. Google Scholar
Catto, I. A., Jacobs, M. R., Shlaes, D. M.Streptococcus mitis. A cause of serious infection in adults. Arch. Intern. Med. 147 (1987) 885–888. Google Scholar
Gaudreau, C., Delage, G., Rousseau, D., Cantor, E. D. Bacteremia caused by viridans streptococci in 71 children. Can. Med. Assoc. J. 125 (1981) 1246–1249. Google Scholar
Loesche, W. J. Indigenous human flora and bacteremia. In:Kaplan, E. L., Taranta, A. V. (eds.): Infective endocarditis. American Heart Association, Dallas, TX 1977, pp. 143–176. Google Scholar
Gibbons, R. J., van Houte, J. Bacterial adherence on oral microbial ecology. Annu. Rev. Microbiol. 29 (1975) 19–41. Google Scholar
Nachamkin, I., Dalton, H. P. The clinical significance of streptococcal species isolated from cerebrospinal fluid. Am. J. Clin. Pathol. 79 (1983) 195–199. Google Scholar
Brennan, R. O., Durack, D. T. The viridans streptococci in perspective. In:Remington, J. S., Swartz, M. N. (eds.): Current clinical topics in infectious diseases. Vol. 5, McGraw-Hill International Book Co., New York 1984, pp. 253–289. Google Scholar
Weightman, N. C., Simpson, E. M., Speller, D. C. E., Mott, M. G., Oakhill, A. Bacteremia related to indwelling central venous catheters: prevention, diagnosis and treatment. Eur. J. Clin. Microbiol. Infect. Dis. 7 (1988) 125–129. Google Scholar
Ognibene, F. P., Martin, S. E., Parker, M. M., Schlesinger, T., Roach, P., Burch, C., Shelhamer, J. H., Parillo, J. E. Adult respiratory distress syndrome in patients with severe neutropenia. N. Engl. J. Med. 315 (1986) 547–551. Google Scholar
Steiner, M., Villablanca, J., Kersey, J., Ramsay, N., Ferrier, M., Haake, R., Weisdorf, D.: α-streptococcal shock in bone marrow transplantation patients. Blood 72 (Suppl. 1) (1988) 409a.
Arning, M., Gehrt, A., Runde, V., Aul, C., Winkelmann, M., Hadding, U. Septicemia caused by_Streptococcus mitis_ in neutropenic patients with leukemia. Blut 59 (1989) 327. Google Scholar
Vansteenkiste, J. F., Boogaerts, M. A. Adult respiratory distress syndrome in neutropenic leukemia patients. Blut 58 (1989) 287–290. Google Scholar
Groot-Loonen, J. J., van der Noordaa, J., de Kraker, J., Voute, P. A., van Leeuwen, E. F., Terpstra, W. J., Ansink-Schipper, M. C. Alpha-hemolytic streptococcal septicemia with severe complications during neutropenia in childhood cancer. Pediatr. Hematol. Oncol. 4 (1987) 323–328. Google Scholar
Haupt, H. M., Hutchins, G. M., Moore, G. W. Ara-C lung: noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia. Am. J. Med. 70 (1981) 256–261. Google Scholar
Quinn, J. P., DiVicenzo, C. A., Lucks, D. A., Luskin, R. L., Shatzer, K. L., Lerner, S. A. Serious infections due to penicillin-resistant strains of viridans strreptococci with altered penicillin-binding proteins. J. Infect. Dis. 157 (1988) 764–769. Google Scholar
Bourgault, A. M., Wilson, W. R., Washington, J. A. II Antimicrobial susceptibility of species of viridans streptococci. J. Infect. Dis. 140 (1979) 316-A321. Google Scholar
Goldfarb, J., Wormser, G. P., Glaser, J. H. Meningitis caused by multiply antibiotic-resistant viridans streptococci. J. Pediatr. 105 (1984) 891–895. Google Scholar
Rahman, M. Penicillin resistance in viridans streptococci. J. Infect. 4 (1982) 89–90. Google Scholar
Karp, J. E., Dick, J. D., Angelopulos, C., Charache, P., Green, L., Burke, P. J., Saral, R. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am. J. Med. 81 (1986) 237–242. Google Scholar
Shenep, J. L., Hughes, W. T., Roberson, P. K., Blankenship, K. R., Baker, D. K., Meyer, W. H., Gigliotti, F., Sixbey, J. W., Santana, V. M., Feldman, S., Lott, L. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N. Engl. J. Med. 319 (1988) 1053–1058. Google Scholar
Hovgaard, D., Skinhj, P., Bangsborg, J., Bruun, B., Hansen, M. M., Nissen, N. I. Bacteremia and candidemia in hematological malignancies: clinical findings. Scand. J. Infect. Dis. 20 (1988) 495–501. Google Scholar